Irish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

hyperplasia/tyrosine

Sábháiltear an nasc chuig an gearrthaisce
Leathanach 1 ó 19 torthaí

Tyrosine kinase inhibitors

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
BACKGROUND OF THE INVENTION This invention relates to salt forms of the compound N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N'-[3-(1-methyl-1H-pyrazol-4-yl)-- 5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamide, an inhibitor of tyrosine kinases, in particular the receptor tyrosine kinase MET,

Altered intracellular localization of BRK/Sik protein tyrosine kinase in human prostate tumors

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION The invention relates to methods for detecting an abnormal prostate condition in an animal. Specifically, the invention relates to methods of detecting an abnormal prostate condition in an animal by detecting the amount of Breast Tumor Kinase (BRK) protein present in the
This invention relates generally to the medical and veterinary medical field of atherosclerotic lesion treatment. More particularly, this invention relates to a catheter device and a method for the local delivery into the vessel wall of specific inhibitors of protein kinase C (PKC) and tyrosine
The present invention relates to the compound of formula (I), ##STR00002## which has valuable pharmacological properties, particularly an inhibiting effect on signal transduction mediated by tyrosine kinases, processes for stereoselectively preparing this compound, particularly pharmaceutical
The present invention relates to the compound of formula (I), ##STR00002## which has valuable pharmacological properties, particularly an inhibiting effect on signal transduction mediated by tyrosine kinases, processes for stereoselectively preparing this compound, particularly pharmaceutical
The present invention relates to the compound of formula (I), ##STR00002## which has valuable pharmacological properties, particularly an inhibiting effect on signal transduction mediated by tyrosine kinases, processes for stereoselectively preparing this compound, particularly pharmaceutical

Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION The present invention relates to bicyclic heterocycles of the general formula ##STR00002## their tautomers, their stereoisomers, their mixtures and their salts, in particular their physiologically tolerable salts with inorganic or organic acids, which have valuable

Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for production of same

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
This application is the national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/EP2007/061842, filed Nov. 3, 2007, which claims priority to European Application No. 06123820.0, filed Nov. 10, 2006, each of which is hereby incorporated by reference in its entirety. The

Spirocyclic heterocycles medicaments containing said compounds, use thereof and method for their production

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
The present invention relates to spirocyclic heterocycles of general formula ##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable pharmacological

Spirocyclic heterocycles medicaments containing said compounds, use thereof and method for their production

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
The present invention relates to spirocyclic heterocycles of general formula ##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable pharmacological

Cyclohexyloxy-substituted heterocyclics, medicines containing these compounds and method for the production thereof

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
The present invention relates to cyclohexyloxy-substituted heterocycles of general formula ##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable

Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
The present invention relates to cyclohexyloxy-substituted heterocycles of general formula ##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable

Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
This application is the national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/EP2008/051141, filed Jan. 30, 2008, which claims priority to European Application No. 07101785.9, filed Feb. 6, 2007, and European Application No. 07118700.9, filed Oct. 17, 2007, each of

Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
The present invention relates to bicyclic heterocycles of general formula ##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids which have valuable pharmacological

Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
The present invention relates to bicyclic heterocycles of general formula ##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable pharmacological
Bí ar ár
leathanach facebook

An bunachar luibheanna míochaine is iomláine le tacaíocht ón eolaíocht

  • Oibreacha i 55 teanga
  • Leigheasanna luibhe le tacaíocht ón eolaíocht
  • Aitheantas luibheanna de réir íomhá
  • Léarscáil GPS idirghníomhach - clibeáil luibheanna ar an láthair (ag teacht go luath)
  • Léigh foilseacháin eolaíochta a bhaineann le do chuardach
  • Cuardaigh luibheanna míochaine de réir a n-éifeachtaí
  • Eagraigh do chuid spéiseanna agus fanacht suas chun dáta leis an taighde nuachta, trialacha cliniciúla agus paitinní

Clóscríobh symptom nó galar agus léigh faoi luibheanna a d’fhéadfadh cabhrú, luibh a chlóscríobh agus galair agus comharthaí a úsáidtear ina choinne a fheiceáil.
* Tá an fhaisnéis uile bunaithe ar thaighde eolaíoch foilsithe

Google Play badgeApp Store badge